Bio Green Energy Tech PCL Statistics

Total Valuation

BKK:BIOTEC has a market cap or net worth of THB 580.14 million. The enterprise value is 1.34 billion.

Market Cap	580.14M
Enterprise Value	1.34B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

BKK:BIOTEC has 3.05 billion shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	n/a
Shares Outstanding	3.05B
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	45.84%
Owned by Institutions (%)	n/a
Float	1.06B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.13
PB Ratio	0.53
P/TBV Ratio	1.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.71, with an EV/FCF ratio of 8.41.

EV / Earnings	-16.15
EV / Sales	0.29
EV / EBITDA	12.71
EV / EBIT	n/a
EV / FCF	8.41

Financial Position

The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.93.

Current Ratio	0.57
Quick Ratio	0.36
Debt / Equity	0.93
Debt / EBITDA	9.68
Debt / FCF	6.39
Interest Coverage	-0.10

Financial Efficiency

Return on equity (ROE) is -7.21% and return on invested capital (ROIC) is -0.16%.

Return on Equity (ROE)	-7.21%
Return on Assets (ROA)	-0.13%
Return on Invested Capital (ROIC)	-0.16%
Return on Capital Employed (ROCE)	-0.40%
Revenue Per Employee	22.54M
Profits Per Employee	-411,557
Employee Count	201
Asset Turnover	1.57
Inventory Turnover	17.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.42% in the last 52 weeks. The beta is 0.29, so BKK:BIOTEC's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-42.42%
50-Day Moving Average	0.19
200-Day Moving Average	0.25
Relative Strength Index (RSI)	47.14
Average Volume (20 Days)	732,740

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BKK:BIOTEC had revenue of THB 4.53 billion and -82.72 million in losses. Loss per share was -0.03.

Revenue	4.53B
Gross Profit	131.35M
Operating Income	-5.81M
Pretax Income	-71.95M
Net Income	-82.72M
EBITDA	78.70M
EBIT	-5.81M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 265.19 million in cash and 1.01 billion in debt, giving a net cash position of -749.68 million or -0.25 per share.

Cash & Cash Equivalents	265.19M
Total Debt	1.01B
Net Cash	-749.68M
Net Cash Per Share	-0.25
Equity (Book Value)	1.09B
Book Value Per Share	0.36
Working Capital	-551.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 191.44 million and capital expenditures -32.52 million, giving a free cash flow of 158.93 million.

Operating Cash Flow	191.44M
Capital Expenditures	-32.52M
Free Cash Flow	158.93M
FCF Per Share	0.05

Full Cash Flow Statement

Margins

Gross margin is 2.90%, with operating and profit margins of -0.13% and -1.81%.

Gross Margin	2.90%
Operating Margin	-0.13%
Pretax Margin	-1.59%
Profit Margin	-1.81%
EBITDA Margin	1.74%
EBIT Margin	-0.13%
FCF Margin	3.51%

Dividends & Yields

BKK:BIOTEC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	-0.00%
Earnings Yield	-14.26%
FCF Yield	27.39%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BKK:BIOTEC has an Altman Z-Score of 1.5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.5
Piotroski F-Score	n/a